iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Trading Down 2.5% – Here’s What Happened

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) shares fell 2.5% during mid-day trading on Tuesday . The company traded as low as $19.88 and last traded at $19.98. 23,050 shares traded hands during trading, a decline of 23% from the average session volume of 30,046 shares. The stock had previously closed at $20.49.

iShares Genomics Immunology and Healthcare ETF Stock Down 2.4 %

The company’s fifty day moving average is $22.14 and its 200 day moving average is $23.23. The stock has a market cap of $103.53 million, a PE ratio of 23.45 and a beta of 1.03.

Hedge Funds Weigh In On iShares Genomics Immunology and Healthcare ETF

A hedge fund recently raised its stake in iShares Genomics Immunology and Healthcare ETF stock. Avior Wealth Management LLC increased its stake in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) by 180.5% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 26,650 shares of the company’s stock after acquiring an additional 17,150 shares during the period. Avior Wealth Management LLC owned approximately 0.46% of iShares Genomics Immunology and Healthcare ETF worth $603,000 at the end of the most recent reporting period.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.